Zhaoyang Chen;Lina Siltala-Li;Mikko Lassila;Pekka Malo;Eeva Vilkkumaa;Tarja Saaresranta;Arho Veli Virkki
{"title":"Predicting Visit Cost of Obstructive Sleep Apnea Using Electronic Healthcare Records With Transformer","authors":"Zhaoyang Chen;Lina Siltala-Li;Mikko Lassila;Pekka Malo;Eeva Vilkkumaa;Tarja Saaresranta;Arho Veli Virkki","doi":"10.1109/JTEHM.2023.3276943","DOIUrl":null,"url":null,"abstract":"Background: Obstructive sleep apnea (OSA) is growing increasingly prevalent in many countries as obesity rises. Sufficient, effective treatment of OSA entails high social and financial costs for healthcare. Objective: For treatment purposes, predicting OSA patients’ visit expenses for the coming year is crucial. Reliable estimates enable healthcare decision-makers to perform careful fiscal management and budget well for effective distribution of resources to hospitals. The challenges created by scarcity of high-quality patient data are exacerbated by the fact that just a third of those data from OSA patients can be used to train analytics models: only OSA patients with more than 365 days of follow-up are relevant for predicting a year’s expenditures. Methods and procedures: The authors propose a translational engineering method applying two Transformer models, one for augmenting the input via data from shorter visit histories and the other predicting the costs by considering both the material thus enriched and cases with more than a year’s follow-up. This method effectively adapts state-of-the-art Transformer models to create practical cost prediction solutions that can be implemented in OSA management, potentially enhancing patient care and resource allocation. Results: The two-model solution permits putting the limited body of OSA patient data to productive use. Relative to a single-Transformer solution using only a third of the high-quality patient data, the solution with two models improved the prediction performance’s \n<inline-formula> <tex-math>$R^{2}$ </tex-math></inline-formula>\n from 88.8% to 97.5%. Even using baseline models with the model-augmented data improved the \n<inline-formula> <tex-math>$R^{2}$ </tex-math></inline-formula>\n considerably, from 61.6% to 81.9%. Conclusion: The proposed method makes prediction with the most of the available high-quality data by carefully exploiting details, which are not directly relevant for answering the question of the next year’s likely expenditure. Clinical and Translational Impact Statement: Public Health– Lack of high-quality source data hinders data-driven analytics-based research in healthcare. The paper presents a method that couples data augmentation and prediction in cases of scant healthcare data.","PeriodicalId":54255,"journal":{"name":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","volume":"11 ","pages":"306-317"},"PeriodicalIF":3.7000,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=10128115","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Journal of Translational Engineering in Health and Medicine-Jtehm","FirstCategoryId":"5","ListUrlMain":"https://ieeexplore.ieee.org/document/10128115/","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Obstructive sleep apnea (OSA) is growing increasingly prevalent in many countries as obesity rises. Sufficient, effective treatment of OSA entails high social and financial costs for healthcare. Objective: For treatment purposes, predicting OSA patients’ visit expenses for the coming year is crucial. Reliable estimates enable healthcare decision-makers to perform careful fiscal management and budget well for effective distribution of resources to hospitals. The challenges created by scarcity of high-quality patient data are exacerbated by the fact that just a third of those data from OSA patients can be used to train analytics models: only OSA patients with more than 365 days of follow-up are relevant for predicting a year’s expenditures. Methods and procedures: The authors propose a translational engineering method applying two Transformer models, one for augmenting the input via data from shorter visit histories and the other predicting the costs by considering both the material thus enriched and cases with more than a year’s follow-up. This method effectively adapts state-of-the-art Transformer models to create practical cost prediction solutions that can be implemented in OSA management, potentially enhancing patient care and resource allocation. Results: The two-model solution permits putting the limited body of OSA patient data to productive use. Relative to a single-Transformer solution using only a third of the high-quality patient data, the solution with two models improved the prediction performance’s
$R^{2}$
from 88.8% to 97.5%. Even using baseline models with the model-augmented data improved the
$R^{2}$
considerably, from 61.6% to 81.9%. Conclusion: The proposed method makes prediction with the most of the available high-quality data by carefully exploiting details, which are not directly relevant for answering the question of the next year’s likely expenditure. Clinical and Translational Impact Statement: Public Health– Lack of high-quality source data hinders data-driven analytics-based research in healthcare. The paper presents a method that couples data augmentation and prediction in cases of scant healthcare data.
期刊介绍:
The IEEE Journal of Translational Engineering in Health and Medicine is an open access product that bridges the engineering and clinical worlds, focusing on detailed descriptions of advanced technical solutions to a clinical need along with clinical results and healthcare relevance. The journal provides a platform for state-of-the-art technology directions in the interdisciplinary field of biomedical engineering, embracing engineering, life sciences and medicine. A unique aspect of the journal is its ability to foster a collaboration between physicians and engineers for presenting broad and compelling real world technological and engineering solutions that can be implemented in the interest of improving quality of patient care and treatment outcomes, thereby reducing costs and improving efficiency. The journal provides an active forum for clinical research and relevant state-of the-art technology for members of all the IEEE societies that have an interest in biomedical engineering as well as reaching out directly to physicians and the medical community through the American Medical Association (AMA) and other clinical societies. The scope of the journal includes, but is not limited, to topics on: Medical devices, healthcare delivery systems, global healthcare initiatives, and ICT based services; Technological relevance to healthcare cost reduction; Technology affecting healthcare management, decision-making, and policy; Advanced technical work that is applied to solving specific clinical needs.